Stock Analysis on Net

Cigna Group (NYSE:CI)

Balance Sheet: Assets

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Cigna Group, consolidated balance sheet: assets

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Cash and cash equivalents 7,822 5,924 5,081 10,182 4,619
Investments 925 905 920 1,331 937
Pharmaceutical manufacturers receivable 8,169 7,108 5,463 4,676 3,439
Noninsurance customer receivables 8,044 6,899 6,274 5,534 5,143
Insurance customer receivables 2,359 2,963 2,932 1,789 2,321
Other receivables 272 248 456 192 334
Less: Accounts receivable, net classified as Assets of businesses held for sale (1,122) (54) (521)
Accounts receivable, net 17,722 17,218 15,071 12,191 10,716
Inventories 5,645 4,777 3,722 3,165 2,661
Other current assets 2,169 1,296 1,283 930 1,400
Assets of businesses held for sale 3,068 10,057 9,512
Current assets 37,351 30,120 36,134 27,799 29,845
Long-term investments 17,985 16,288 18,438 23,262 21,542
Reinsurance recoverables 4,835 4,743 4,970 5,200 5,100
Property and equipment 3,695 3,774 3,692 4,205 4,417
Goodwill 44,259 45,811 45,811 44,648 44,602
Other intangible assets 30,863 32,492 34,102 35,179 36,562
Other assets 3,421 3,426 3,405 6,072 5,241
Separate account assets 7,430 7,278 8,337 9,086 8,465
Assets of businesses held for sale, non-current 2,922
Non-current assets 115,410 113,812 118,755 127,652 125,929
Total assets 152,761 143,932 154,889 155,451 155,774

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


Assets: Selected Items

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Cigna Group current assets decreased from 2021 to 2022 but then increased from 2022 to 2023 exceeding 2021 level.
Property and equipment Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Cigna Group property and equipment increased from 2021 to 2022 but then slightly decreased from 2022 to 2023 not reaching 2021 level.
Non-current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Cigna Group non-current assets decreased from 2021 to 2022 but then slightly increased from 2022 to 2023.
Total assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Cigna Group total assets decreased from 2021 to 2022 but then increased from 2022 to 2023 not reaching 2021 level.

Current Assets: Selected Items

Balance sheet item Description The company
Cash and cash equivalents Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Cigna Group cash and cash equivalents increased from 2021 to 2022 and from 2022 to 2023.
Investments Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. Cigna Group investments decreased from 2021 to 2022 but then increased from 2022 to 2023 exceeding 2021 level.
Accounts receivable, net The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value. Cigna Group accounts receivable, net increased from 2021 to 2022 and from 2022 to 2023.
Inventories Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Cigna Group inventories increased from 2021 to 2022 and from 2022 to 2023.